Emkay

Emkay Global Financial — TradingView News

Emkay Global Financial’ research report on PI Industries Kumiai Chemical Industry (Kumiai) has revised up its H1FY25 revenue guidance by ~9% to JPY96bn from JPY88bn, citing that net sales are expected to
9 months ago

Emkay Global Financial — TradingView News

Emkay Global Financial’ research report on Global Health Global Health (Medanta)’s Q4FY25 print was in line with street/our estimates. The Developing portfolio continued its healthy trajectory, as OBD grew 36% YoY (favorable
10 months ago

Emkay Global Financial — TradingView News

Emkay Global Financial’ research report on REC REC reported a soft quarter, with moderating growth and disbursement led by higher repayments (including prepayments) and NPA resolutions, while margin and asset quality were
10 months ago

Emkay Global Financial — TradingView News

Emkay Global Financial’ research report on Britannia Industries With improvement in macro trends, the management is reasonably optimistic about the sector recovery. It endeavors to attain double-digit growth ahead, and expects adjacent
10 months ago

Emkay Global Financial — TradingView News

Emkay Global Financial’s research report on Sonata Software Sonata posted a weak operating performance in International IT Services (IITS) in Q4. IITS revenue declined 7.2% QoQ CC, below our expectations. The decline
10 months ago

Emkay Global Financial — TradingView News

Emkay Global Financial’s research report on Ethos Ethos’s Q4 EBITDA is in-line, with margin up by 80bps offsetting the 6% miss on revenue. Despite this, revenue growth was a decent 23%/25% in
10 months ago

Emkay Global Financial — TradingView News

Emkay Global Financial’s research report on Epigral Epigral posted in-line results, with revenue/EBITDA/PAT up 20%/12%/12% YoY. This was largely led by i) improvement in ECUs in the caustic soda business and higher
10 months ago

Emkay Global Financial — TradingView News

Emkay Global Financial’s research report on State Bank of India SBI posted a slightly soft quarter, as credit growth moderated to 12.4% YoY due to pre-payments in the corporate book, while higher
10 months ago

Emkay Global Financial — TradingView News

Emkay Global Financial’s research report on Indian Bank Indian Bank reported healthy credit growth at ~11% YoY/5.3% QoQ, but NIMs retraced to 3.4% levels (similar to Q2) due to impact of recent
10 months ago

Emkay Global Financial — TradingView News

Emkay Global Financial’s research report on Vedanta VED reported a steady Q4FY25 with EBITDA of Rs116.2bn (+4.5% vs Emkay; +3.0% QoQ); the performance was mainly led by sequentially better profitability in its
10 months ago